BLACKROCK ESG CAP ALL TRM TR (ECAT) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:ECAT - US09262F1003
15.33 USD
+0.13 (+0.86%)
15.51 USD
+0.18 (+1.17%)
We assign a fundamental rating of 2 out of 10 to ECAT. ECAT was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of ECAT have multiple concerns. ECAT does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
ECAT had positive earnings in the past year.
ECAT had a positive operating cash flow in the past year.
1.2 Ratios
The last Return On Invested Capital (1.35%) for ECAT is above the 3 year average (1.31%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.5% | ||
| ROE | 9.29% | ||
| ROIC | 1.35% |
ROA(3y)4.06%
ROA(5y)N/A
ROE(3y)3.82%
ROE(5y)N/A
ROIC(3y)1.31%
ROIC(5y)N/A
1.3 Margins
ECAT's Profit Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 52.96% | ||
| PM (TTM) | 285.19% | ||
| GM | 59.26% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-48.47%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
ECAT has less shares outstanding than it did 1 year ago.
ECAT has a better debt/assets ratio than last year.
2.2 Solvency
ECAT has an Altman-Z score of 5.86. This indicates that ECAT is financially healthy and has little risk of bankruptcy at the moment.
The Debt to FCF ratio of ECAT is 0.01, which is an excellent value as it means it would take ECAT, only 0.01 years of fcf income to pay off all of its debts.
A Debt/Equity ratio of 0.00 indicates that ECAT is not too dependend on debt financing.
Although ECAT does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.01 | ||
| Altman-Z | 5.86 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
ECAT has a Current Ratio of 0.05. This is a bad value and indicates that ECAT is not financially healthy enough and could expect problems in meeting its short term obligations.
ECAT has a Quick Ratio of 0.05. This is a bad value and indicates that ECAT is not financially healthy enough and could expect problems in meeting its short term obligations.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.05 | ||
| Quick Ratio | 0.05 |
3. Growth
3.1 Past
The earnings per share for ECAT have decreased strongly by -40.23% in the last year.
The Earnings Per Share has been growing by 45.23% on average over the past years. This is a very strong growth
The Revenue for ECAT has decreased by -13.09% in the past year. This is quite bad
Measured over the past years, ECAT shows a very strong growth in Revenue. The Revenue has been growing by 175.73% on average per year.
EPS 1Y (TTM)-40.23%
EPS 3Y45.23%
EPS 5YN/A
EPS Q2Q%-47.46%
Revenue 1Y (TTM)-13.09%
Revenue growth 3Y175.73%
Revenue growth 5YN/A
Sales Q2Q%-23.53%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 9.83 indicates a reasonable valuation of ECAT.
ECAT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.45.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.83 | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.74 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
ECAT has a Yearly Dividend Yield of 23.26%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.42, ECAT pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 23.26% |
5.2 History
ECAT has been paying a dividend for over 5 years, so it has already some track record.
ECAT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
235.71% of the earnings are spent on dividend by ECAT. This is not a sustainable payout ratio.
DP235.71%
EPS Next 2YN/A
EPS Next 3YN/A
15.33
+0.13 (+0.86%)
Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)
Earnings (Next)
Inst Owners43.59%
Inst Owner Change-5.76%
Ins Owners0.11%
Ins Owner Change0%
Market Cap1.52B
Revenue(TTM)54.00M
Net Income(TTM)154.00M
Analysts0
Price TargetN/A
Short Float %0.3%
Short Ratio0.82
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 23.26% |
Yearly Dividend2.87
Dividend Growth(5Y)N/A
DP235.71%
Div Incr Years3
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.83 | ||
| Fwd PE | N/A | ||
| P/S | 28.2 | ||
| P/FCF | 3.74 | ||
| P/OCF | 3.74 | ||
| P/B | 0.92 | ||
| P/tB | 0.92 | ||
| EV/EBITDA | N/A |
EPS(TTM)1.56
EY10.18%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)4.1
FCFY26.72%
OCF(TTM)4.1
OCFY26.72%
SpS0.54
BVpS16.67
TBVpS16.67
PEG (NY)N/A
PEG (5Y)N/A
Graham Number24.19
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.5% | ||
| ROE | 9.29% | ||
| ROCE | 1.71% | ||
| ROIC | 1.35% | ||
| ROICexc | 1.35% | ||
| ROICexgc | 1.35% | ||
| OM | 52.96% | ||
| PM (TTM) | 285.19% | ||
| GM | 59.26% | ||
| FCFM | 753.7% |
ROA(3y)4.06%
ROA(5y)N/A
ROE(3y)3.82%
ROE(5y)N/A
ROIC(3y)1.31%
ROIC(5y)N/A
ROICexc(3y)1.31%
ROICexc(5y)N/A
ROICexgc(3y)1.34%
ROICexgc(5y)N/A
ROCE(3y)1.67%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-48.47%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.03
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.01 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 264.29% | ||
| Current Ratio | 0.05 | ||
| Quick Ratio | 0.05 | ||
| Altman-Z | 5.86 |
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.23%
EPS 3Y45.23%
EPS 5YN/A
EPS Q2Q%-47.46%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.09%
Revenue growth 3Y175.73%
Revenue growth 5YN/A
Sales Q2Q%-23.53%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-21.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y128.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y128.78%
OCF growth 3YN/A
OCF growth 5YN/A
BLACKROCK ESG CAP ALL TRM TR / ECAT FAQ
Can you describe the business of BLACKROCK ESG CAP ALL TRM TR?
BlackRock ESG Capital Allocation Term Trust is a US-based company operating in industry. The company is headquartered in Wilmington, Delaware. The company went IPO on 2021-09-28. BlackRock ESG Capital Allocation Term Trust (the Trust) is a non-diversified, closed-end management investment company. The Trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. The Trust’s portfolio includes both equity and debt securities. However, the Trust may emphasize either debt securities or equity securities. In addition, the Trust may invest without limit in junk bonds, corporate loans, and distressed securities. The Trust invests at least 80% of its total assets in securities that, in the adviser’s assessment, meet certain environmental, social and governance (ESG) criteria. The Trust intends to invest up to 25% of its total assets, measured at the time of investment, in illiquid privately placed, or restricted securities. BlackRock Advisors, LLC is the Trust's investment adviser.
Can you provide the latest stock price for BLACKROCK ESG CAP ALL TRM TR?
The current stock price of ECAT is 15.33 USD. The price increased by 0.86% in the last trading session.
How is the ChartMill rating for BLACKROCK ESG CAP ALL TRM TR?
ECAT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.